Search

Your search keyword '"Yoneda T"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Yoneda T" Remove constraint Author: "Yoneda T" Topic hypertension Remove constraint Topic: hypertension
31 results on '"Yoneda T"'

Search Results

1. Epigenetic Regulation of the Renin-Angiotensin-Aldosterone System in Hypertension.

2. Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results.

3. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.

4. A hyperaldosteronism subtypes predictive model using ensemble learning.

5. Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.

6. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.

7. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.

8. Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.

9. Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study.

10. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.

11. Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.

12. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.

13. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.

14. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats.

15. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.

16. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.

17. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.

18. RhoA expression is not a critical determinant in hypertension evolution in salt-sensitive Dahl rats.

19. Calcium handling and sarcoplasmic-reticular protein functions during heart-failure transition in ventricular myocardium from rats with hypertension.

20. Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats.

21. Cardiac aldosterone production in genetically hypertensive rats.

22. Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.

23. Vascular aldosterone in genetically hypertensive rats.

24. Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.

25. Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat.

26. Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension.

27. The activities of 5 beta-reductase and 11 beta-hydroxysteroid dehydrogenase in essential hypertension.

28. Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats.

29. 11 beta-Hydroxysteroid dehydrogenase activity in mesenteric arteries of spontaneously hypertensive rats.

30. Increased concentration of endothelin messenger RNA in the mesenteric arteries of cyclosporine-induced hypertensive rats.

31. Endothelin-1 release from mesenteric arteries of spontaneously hypertensive rats.

Catalog

Books, media, physical & digital resources